We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fonebak | LSE:FON | London | Ordinary Share | GB00B06GNN57 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.02 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMRGS
RNS Number : 8807Z
Regenersis PLC
23 September 2015
23 September 2015
REGENERSIS PLC (THE "COMPANY")
DIRECTORS' DEALINGS
The Company has been notified on 22 September 2015 that Hanover Investors bought 200,000 shares in the Company on 22 September 2015 at a price of 147 pence per share.
Following this purchase, Hanover Investors and its connected parties are interested in 5,417,651 ordinary shares, representing 6.9% of the Company's issued share capital. Matthew Peacock, Executive Director, and Tom Russell, Non-Executive Director of the Company, have an indirect beneficial interest in the shares held by Hanover Investors.
Enquiries:
Regenersis Plc +44 (0) 20 3657 7000
Matthew Peacock, Executive Chairman
Jog Dhody, Chief Financial Officer
Peel Hunt LLP (Nomad and Joint Broker) +44 (0) 20 7418 8900
Richard Kauffer
Edward Fox
Panmure Gordon (UK) Limited (Joint Broker) +44 (0) 20 7886 2500
Dominic Morley
Charles Leigh Pemberton
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLTMRTMBJTBLA
(END) Dow Jones Newswires
September 23, 2015 02:01 ET (06:01 GMT)
1 Year Fonebak Chart |
1 Month Fonebak Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions